Login / Signup

Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus.

Yusuke MiyazakiShingo NakayamadaKoshiro SonomotoAkio KawabeYoshino InoueNaoaki OkuboShigeru IwataKentaro HanamiYoshiya Tanaka
Published in: Rheumatology (Oxford, England) (2022)
The present study suggests that BEL is suitable for patients with SLE during maintenance therapy.
Keyphrases
  • systemic lupus erythematosus
  • stem cells
  • rheumatoid arthritis
  • mesenchymal stem cells
  • bone marrow
  • chemotherapy induced